UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Biomarkers in cerebrospinal fluid of patients with bipolar disorder versus healthy individuals: A systematic review

Knorr, U; Simonsen, AH; Zetterberg, H; Blennow, K; Hasselbalch, SG; Kessing, LV; (2018) Biomarkers in cerebrospinal fluid of patients with bipolar disorder versus healthy individuals: A systematic review. European Neuropsychopharmacology , 28 (7) pp. 783-794. 10.1016/j.euroneuro.2018.04.002. Green open access

[thumbnail of Zetterberg_Knorr.pdf]
Preview
Text
Zetterberg_Knorr.pdf - Accepted Version

Download (1MB) | Preview

Abstract

Background: The pathophysiological processes of bipolar disorder (BD) may be detectable by the use of cerebrospinal fluid (CSF) biomarkers. // Aim: We aimed for the first time to review studies of CSF biomarkers in patients with BD compared to healthy control individuals (HC). We investigated the effect of diagnosis, age, gender, clinical state, medication, technical characteristics of tests, fasting state and, cognitive function if applicable. // Method: We did a systematic review according to the PRISMA Statement based on comprehensive database searches for studies on cerebrospinal biomarkers in patients with bipolar disorder versus HC. Risk of bias was systematically assessed. // Results: The search strategy identified 410 studies of which thirty-four fulfilled the inclusion criteria. A total of 117 unique biomarkers were investigated, out of which 11 were evaluated in more than one study. Forty biomarkers showed statistically significant differences between BD and HC in single studies. Only the findings of elevated homovanillic acid and 5-hydroxy-indoleacetic acid were replicated across studies. Most studies had a cross sectional design and were influenced by risk of bias mainly due to small sample size, lack of data on mood state at the time of the CSF puncture and not considering potential confounders including age, gender, diagnoses, BMI, life style factors such as smoking, and psychotropic medication. // Conclusion: Specific monoamine CSF biomarkers may be related to the pathophysiology of BD. Future studies must aim at increasing the level of evidence by validating the positive findings in prospective studies with stringent methodology.

Type: Article
Title: Biomarkers in cerebrospinal fluid of patients with bipolar disorder versus healthy individuals: A systematic review
Open access status: An open access version is available from UCL Discovery
DOI: 10.1016/j.euroneuro.2018.04.002
Publisher version: https://doi.org/10.1016/j.euroneuro.2018.04.002
Language: English
Additional information: This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions.
Keywords: Cerebrospinal fluid, bipolar disorder, biomarker, systematic review
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology > Neurodegenerative Diseases
URI: https://discovery.ucl.ac.uk/id/eprint/10057509
Downloads since deposit
Loading...
383Downloads
Download activity - last month
Loading...
Download activity - last 12 months
Loading...
Downloads by country - last 12 months
Loading...

Archive Staff Only

View Item View Item